Efficacy against variants is showing the drug is the gold standard in preventing COVID.
Every double-digit decline throughout history has proved to be a buying opportunity.
These companies are well-positioned to weather a downturn and safeguard your portfolio from risk.
The metrics for this digital healthcare platform are headed higher for the right reasons.
In Sin City, Tesla vehicles have begun shuttling passengers around underground.
Dogecoin still stands as the year's best-performing asset, but investors should focus on what comes next.
These two digital currencies have the differentiation to stand out in a crowded field.
Multiyear catalysts in this tech company's two biggest businesses make it worth buying.
These fundamentally strong stocks are much better bets than the over-hyped Dogecoin.
Wall Street punished the electric vehicle stock on a weak day.